What Is GHRP-2 Peptide?
GHRP-2, also known as pralmorelin or KP-102, is a synthetic hexapeptide belonging to the growth hormone-releasing peptide family. Researchers classify it as a synthetic growth hormone secretagogue.
Its chemical sequence contains six amino acid residues, giving GHRP-2 the structural characteristics of a small oligopeptide. Researchers developed and characterized GHRP-2 as part of the GHRP class of synthetic peptides.
Research Overview Table
Chemical and Molecular Characteristics
GHRP-2 is a synthetic hexapeptide with a six-residue structure. Its sequence contains D-alanine, D-2-naphthylalanine, alanine, tryptophan, D-phenylalanine and lysinamide. The molecule includes both D- and L-configured residues, along with a naphthyl-containing amino acid residue that contributes to its distinctive molecular architecture.
GHRP-2 has the molecular formula C45H55N9O6 and a molecular weight of 817.97 g/mol. Its structure contains several polar functional groups as well as aromatic regions from the tryptophan, phenylalanine, and naphthylalanine residues. These structural features define its physicochemical profile and distinguish GHRP-2 from larger peptides and proteins.
Certificates:
Mechanism of Action Under Investigation
GHRP-2 interacts with the growth hormone secretagogue receptor (GHSR), a G protein-coupled receptor. Experimental studies have investigated GHRP-2 signaling in pituitary cells and found changes in intracellular calcium, phosphoinositide turnover, protein kinase C (PKC) activity, and cyclic AMP (cAMP). These findings indicate that GHRP-2 can engage several intracellular signaling processes following receptor activation.
Studies in cultured pituitary cells found that GHRP-2 increased intracellular calcium and that calcium-channel blockade reduced the cellular response. Other experiments showed increased phosphatidylinositol hydrolysis and involvement of PKC. Research in human pituitary tumor cells also identified cAMP responses under specific experimental conditions, suggesting interaction between phosphoinositide and adenylyl cyclase signaling.
The precise contribution of each pathway remains uncertain. Results have differed between species and experimental systems, including differences in the relative roles of calcium, PKC, cAMP, and GHRH-related signaling. Therefore, published evidence supports GHSR-associated activity but does not establish one complete downstream signaling pathway for all experimental conditions.
Scientific Research Context
GHRP-2 has a broad research record that includes cell studies, animal studies, and human studies. The literature covers both early experimental research and later studies in different research settings. Most of the available evidence comes from in vitro and animal research, while human studies make up a smaller part of the evidence base. This makes GHRP-2 a relatively well-studied experimental peptide, although the overall literature remains primarily preclinical.
GHRP-2 Biology and Biological Pathways
Primary Biological Function
GHRP-2 research is closely linked to the biology of the growth hormone secretagogue system. GHSR is expressed in the pituitary and hypothalamus and participates in the regulation of growth hormone secretion. Studies have also examined GHSR expression in peripheral tissues, although the biological significance of these findings differs between tissues.
Relevant Metabolic or Signaling Pathways
Studies of GHRP-2 have examined calcium signaling, phosphoinositide turnover, protein kinase C (PKC) and cyclic AMP (cAMP) in pituitary cells. GHRP-2 increased intracellular calcium and calcium-channel activity in cultured ovine somatotrophs. Other studies reported increased phosphatidylinositol turnover and PKC involvement in human pituitary cells. Researchers also observed changes in cAMP under specific experimental conditions.
Tissue-Specific Biology
The pituitary is a major tissue of interest in GHRP-2 research because somatotroph cells express the machinery involved in growth hormone secretion. Research has also examined GHRP-2 and GHSR biology in hypothalamic and peripheral tissues. Studies in muscle cells have investigated GHRP-2-associated changes in muscle-related gene expression, providing evidence for biological effects outside the pituitary.
Experimental Biomarkers
GHRP-2 studies have measured growth hormone, intracellular calcium, cAMP, phosphoinositide turnover, and gene expression. Muscle studies have also measured Atrogin-1 and MuRF1 mRNA in animal muscle and cultured myocytes. These markers reflect the specific biological responses examined in different GHRP-2 research settings.
Laboratory Investigation Methods
Researchers have examined GHRP-2 in cultured pituitary cells, cultured muscle cells, and animal models. Studies have used whole-cell electrophysiology and intracellular calcium measurements to examine pituitary cell responses. Other experiments have measured cAMP and phosphoinositide turnover in pituitary cells, while muscle studies have used gene-expression analysis to measure Atrogin-1 and MuRF1 mRNA.
Experimental Models Used in Published Research
Published GHRP-2 research includes cell-based and animal models. These models differ in species, tissue source, and experimental setting. Such differences affect how closely each model represents human biology and how broadly researchers can apply its findings. The specific strengths and limitations of each model are discussed below.
Primary Pituitary Cells
GHRP-2 has been studied in primary pituitary cells from sheep and cattle. These cells give researchers an isolated pituitary model for laboratory experiments. However, the cells are removed from the intact animal, so the model cannot capture the full interaction between the pituitary and other tissues.
Human Pituitary Tumor Cells
Researchers have used human pituitary tumor cells as an in vitro model for GHRP-2 research. One study used cells obtained from human acromegalic pituitary tumors and maintained them in primary culture. This model provides human pituitary cells for controlled laboratory experiments, but tumor-derived cells may not fully represent normal pituitary somatotrophs.
C2C12 Muscle Cells
Differentiated C2C12 myocytes have been used as an in vitro model in GHRP-2 research. The cells provide a controlled skeletal muscle system for laboratory experiments. As a mouse-derived cell line, C2C12 does not fully represent the cellular environment of intact skeletal muscle or normal muscle tissue in an organism.
Rodent Models
Researchers have tested GHRP-2 in rats and mice, including normal animals and specialized models such as GHRH-deficient mice. These models provide intact endocrine systems for experimental studies. Their main limitation is the difference between rodent and human physiology, particularly in hormone regulation, and receptor biology. Findings from these models therefore cannot directly represent human biology.
Large-Animal Models
Researchers have studied GHRP-2 in swine, cattle, sheep and yaks. These species provide larger-animal models for studying the peptide in an intact biological system. Their main limitation is that endocrine regulation differs across species. Differences in hormone secretion, receptor biology, and physiology can limit how directly findings from these animals apply to humans.
GHRP-2 Published Research
Growth Hormone Secretion
A major area of GHRP-2 research has been growth hormone secretion. Studies have examined GH responses to GHRP-2 alone and alongside GHRH. Researchers have also investigated how factors such as age, sex, exercise, and endocrine status affect the GH response.
Pituitary and Endocrine Regulation
Research has examined GHRP-2 in pituitary and endocrine regulation, including its relationship with GHRH and other regulators of GH secretion. Studies have also investigated GHRP-2 responses in people with altered GH function and in children undergoing evaluation of pituitary GH reserve.
Exercise-Related GH Responses
Studies have investigated GHRP-2 in relation to exercise and growth hormone secretion. Researchers have compared GHRP-2 with exercise, GHRH and L-arginine, including combinations of these stimuli. The studies have focused on the relationship between exercise and GHRP-2-induced GH secretion.
Skeletal Muscle Biology
GHRP-2 has been studied in skeletal muscle biology, with research examining muscle-related gene expression. Studies have focused on Atrogin-1, MuRF1, IGF-I, and IGFBP-5 in skeletal muscle. This research has examined how GHRP-2 relates to changes in genes involved in muscle protein turnover.
Endocrine Factors
GHRP-2 research has examined growth hormone, prolactin, ACTH, cortisol, IGF-I, IGFBP-3, and IGFBP-5. Studies have assessed these endocrine measures alongside GHRP-2 administration under different experimental conditions, including single-dose and repeated administration studies.
Limitations of Current Research
Evidence Is Predominantly Preclinical
GHRP-2 has been studied in humans as well as in experimental systems. However, a large part of the research examines basic biology rather than long-term outcomes in people. This limits how much the experimental evidence can tell us about GHRP-2 beyond the specific conditions tested.
Human Clinical Evidence
Human studies remain limited. Many involved small groups or selected populations, which makes it harder to apply their findings to the wider population. Most studies also focused on growth hormone and related endocrine responses rather than longer-term outcomes.
Species Differences
GHRP-2 responses can vary between species. Differences in receptor activity and endocrine regulation can change how cells and tissues respond to the peptide. These differences make it difficult to assume that findings from one species will occur in the same way in humans.
Study Design Limitations
GHRP-2 studies have used different doses, treatment schedules, and experimental conditions. Some studies also tested GHRP-2 together with GHRH or other hormonal stimuli. These differences can affect the measured response and make results from separate studies harder to compare.
Independent Replication
The GHRP-2 literature includes studies from different research groups, but replication varies across research areas. Several studies have examined similar questions about GH responses, while some other areas have fewer published investigations. This makes the evidence base less consistent across all aspects of GHRP-2 research.
Long-Term Evidence
Researchers have studied GHRP-2 for periods of up to 30 days in controlled human research. However, evidence over much longer periods remains limited. The available studies therefore provide less information about responses to prolonged exposure.
Analytical Documentation
High-Performance Liquid Chromatography (HPLC) separates GHRP-2 from other compounds and helps measure peptide purity. Researchers have used HPLC to analyze and quantify GHRP-2 in laboratory studies.
Liquid Chromatography–Mass Spectrometry (LC-MS) combines separation with mass analysis. Researchers have used LC-MS and LC-MS/MS to identify GHRP-2 and its metabolites in biological samples.
Nuclear Magnetic Resonance (NMR) can provide additional structural information. Researchers have used NMR together with mass spectrometry to identify GHRP-2 in analytical samples.
A Certificate of Analysis records the test results for a specific batch. These records help researchers verify the material's identity and quality before laboratory use. Analytical documentation verifies product identity and quality, not biological performance.
Storage and Laboratory Handling
Store GHRP-2 according to the storage conditions listed on the product documentation. The supplied Certificate of Analysis specifies 2–8°C. Keep the material protected from moisture, heat, and direct light, and keep the container closed when not in use.
Handle GHRP-2 in a clean laboratory environment and use appropriate laboratory practices to reduce contamination. Qualified laboratory personnel should handle and store the material according to institutional procedures and the applicable product documentation. GHRP-2 from Direct Sarms Slovenia should remain restricted to laboratory research use only.
Frequently asked questions
Why choose us?
Direct SARMs Slovenia is an established supplier of research peptides. We are committed to product quality, reliable service, and helpful customer support.
Our European-made products undergo rigorous purity testing, with clear product information provided for each research material. We also aim to provide dependable shipping and a smooth ordering experience.
Our support team is available to assist with orders, shipping, payments, and general questions. At Direct SARMs Slovenia, we aim to make the research supply process simple, clear, and reliable.